191 Dietary salt promotes cognitive impairment through tau phosphorylation.

190 Autism spectrum traits predict higher social psychological skill.

189 Prenatal exposure to organophosphate pesticides and functional neuroimaging in adolescents living in proximity to pesticide application.

188 Anticholinergic Drug Exposure and the Risk of Dementia.

187 Association of Lifestyle and Genetic Risk With Incidence of Dementia.

186 Anti–Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.

185 Neuroimaging Findings in US Government Personnel With Possible Exposure to Directional Phenomena in Havana, Cuba.

184 Trial of Galcanezumab in Prevention of Episodic Cluster Headache.

183 Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine.

182 Detection of Brain Activation in Unresponsive Patients with Acute Brain Injury.

181 Anticholinergic Drug Exposure and the Risk of Dementia.

180 Targeting Huntingtin Expression in Patients with Huntington’s Disease.

179 Music in premature infants enhances high-level cognitive brain networks.

178 Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice.

177 Adrenergic receptor antagonism induces neuroprotection and facilitates recovery from acute ischemic stroke.

176 Macrophage centripetal migration drives spontaneous healing process after spinal cord injury.

175 A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.

174 A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder.

173 Preventing adolescent stress-induced cognitive and microbiome changes by diet.

172 Tau Positron-Emission Tomography in Former National Football League Players.

Free Images for Presentation: sunipix SUNIPIX